Skip to main content

Table 3 Median prices and Median Price Ratios of anti-malarials being sold in private and not-for-profit outlets

From: Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya

 

Outlet type

Anti-malarials

Private

Not-for-profit

 

Median price (range) USD

Median price ratio

Median price (range) USD

Median price ratio

AL*

0.94 (0.63-1.25)

1.88

0.75 (0.63-1.00)

1.5

Other forms of ACT**

6.0 (1.88-10.63)

12

2.5 (1.88-3.13)

5

Quinine*

1.0 (0.75-1.25)

1.33

0.75 (0.63-1.13)

1

  1. USD, United States Dollars; ACT, artemisinin-based combination therapy; AL, artemether-lumefantrine.
  2. *Median price ratio was calculated using median price of quinine in not-for-profit as reference since there is no government subsidized price.
  3. **Median price ratio was calculated as anti-malarial median price to the government recommended price of subsidized ACT (AL) (KES 40, USD 0.5).